Hims & Hers Health, INC Form 4 insider transactions

Hims & Hers Health CEO Andrew Dudum sold shares of Class A Common Stock on June 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Chief Commercial Officer Michael Chi exercised stock options and sold shares of Hims & Hers Health, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, reports the vesting and disposal of restricted stock units to cover tax obligations, resulting in adjustments to their holdings of Class A Common Stock.

Irene Becklund, PAO of Hims & Hers Health, reports multiple transactions involving Class A Common Stock, including acquisitions, disposals, and option exercises, according to a Form 4 filing.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, reports the vesting of restricted stock units, subsequent tax withholding, and sale of shares under a pre-arranged trading plan.

Director David B. Wells reports the vesting and conversion of restricted stock units into Class A Common Stock.

Chief Medical Officer Patrick Harrison Carroll reports transactions involving Hims & Hers Health, Inc. Class A Common Stock, including the vesting of Restricted Stock Units (RSUs) and shares withheld for tax obligations.

Andrew Dudum, CEO of Hims & Hers Health, reports the vesting and settlement of restricted stock units and related tax withholding.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units on June 14, 2024, due to vesting of RSUs and tax withholding.

Chief Financial Officer of Hims & Hers Health, Oluyemi Okupe, reports the vesting and subsequent tax withholding of Class A Common Stock.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,510 shares of Class A Common Stock at a price of $21.47 per share on June 11, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. reports exercising stock options and selling Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Lynne Chou O'Keefe, a director of Hims & Hers Health, Inc., reported the vesting of 19,707 Restricted Stock Units (RSUs) on June 6, 2024, convertible to Class A Common Stock.

Director Delos M. Cosgrove reports the vesting of restricted stock units (RSUs) into Class A Common Stock of Hims & Hers Health, Inc.

Director David B. Wells reports the vesting and conversion of Restricted Stock Units (RSUs) into Class A Common Stock of Hims & Hers Health, Inc.

Director Andrea Perez Garcia reports vesting of restricted stock units into Class A Common Stock of Hims & Hers Health, Inc.

Director Christiane Pendarvis reports the vesting of 19,707 Restricted Stock Units (RSUs) convertible to Class A Common Stock on June 6, 2024, resulting in a total direct ownership of 30,917 Class A Common Stock shares.

Chief Medical Officer of Hims & Hers Health, Patrick Harrison Carroll, reports the vesting and acquisition of 19,707 Class A Common Stock units on June 6, 2024, increasing his direct holdings to 193,587 shares.

Director Ambar Bhattacharyya reported the vesting of 19,707 shares of Class A Common Stock and Restricted Stock Units (RSUs) on June 6, 2024.

Hims & Hers Health CFO Oluyemi Okupe exercised stock options and sold shares of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Director Alex Bard reports vesting of Restricted Stock Units (RSUs) convertible to Class A Common Stock.

CEO Andrew Dudum exercised stock options and sold shares of Hims & Hers Health, Inc. on June 4, 2024, according to a Form 4 filing with the SEC.

Melissa Baird, COO of Hims & Hers Health, executed stock options and sold Class A Common Stock between June 3rd and June 5th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., exercised stock options and sold shares of Class A Common Stock between May 31, 2024, and June 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,502 shares of Class A Common Stock at a price of $17.33 per share on May 28, 2024, under a pre-arranged trading plan.

Oluyemi Okupe, CFO of Hims & Hers Health, executed stock option exercises and sales of Class A Common Stock under a pre-arranged 10b5-1 trading plan.

Director Christopher Payne purchased 110,000 shares of Hims & Hers Health, Inc. at an average price of $17.7433 on May 21, 2024.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Irene Becklund, PAO of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock under a pre-arranged 10b5-1 trading plan.